Report overview
This report contains market size and forecasts of Biologic Drugs in global, including the following market information:
Global Biologic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Biologic Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Biologic Drugs companies in 2021 (%)
The global Biologic Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Humira Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biologic Drugs include Roche, Abbott Laboratories, Johnson & Johnson, Merck & Co., Pfizer, Amgen, Sanofi, Novartis and Eli Lilly and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biologic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biologic Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biologic Drugs Market Segment Percentages, by Type, 2021 (%)
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others
Global Biologic Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biologic Drugs Market Segment Percentages, by Application, 2021 (%)
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others
Global Biologic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biologic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biologic Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Biologic Drugs revenues share in global market, 2021 (%)
Key companies Biologic Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Biologic Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen
